News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
274,777 Results
Type
Article (14580)
Company Profile (281)
Press Release (259905)
Multimedia
Podcasts (65)
Webinars (12)
Section
Business (79701)
Career Advice (154)
Deals (13274)
Drug Delivery (38)
Drug Development (50631)
Employer Resources (31)
FDA (5782)
Job Trends (5159)
News (144815)
Policy (10068)
Tag
Academia (917)
Accelerated approval (8)
Adcomms (14)
Allergies (63)
Alliances (21764)
ALS (91)
Alzheimer's disease (935)
Antibody-drug conjugate (ADC) (140)
Approvals (5842)
Artificial intelligence (175)
Autoimmune disease (32)
Automation (7)
Bankruptcy (105)
Best Places to Work (4563)
BIOSECURE Act (6)
Biosimilars (64)
Biotechnology (231)
Bladder cancer (79)
Brain cancer (30)
Breast cancer (227)
Cancer (2136)
Cardiovascular disease (169)
Career advice (136)
Career pathing (2)
CAR-T (158)
CDC (4)
Cell therapy (422)
Cervical cancer (11)
Clinical research (42183)
Collaboration (787)
Company closure (2)
Compensation (423)
Complete response letters (27)
COVID-19 (1070)
CRISPR (70)
C-suite (309)
Cystic fibrosis (92)
Data (2529)
Denatured (13)
Depression (59)
Diabetes (195)
Diagnostics (1327)
Digital health (4)
Diversity (3)
Diversity, equity & inclusion (9)
Drug discovery (119)
Drug pricing (36)
Drug shortages (3)
Duchenne muscular dystrophy (162)
Earnings (30930)
Editorial (21)
Employer branding (4)
Employer resources (29)
Events (50012)
Executive appointments (567)
FDA (6965)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (689)
Gene editing (137)
Generative AI (12)
Gene therapy (358)
GLP-1 (439)
Government (1120)
Grass and pollen (2)
Guidances (142)
Healthcare (6609)
HIV (12)
Huntington's disease (30)
IgA nephropathy (44)
Immunology and inflammation (136)
Immuno-oncology (7)
Indications (29)
Infectious disease (1147)
Inflammatory bowel disease (134)
Inflation Reduction Act (9)
Influenza (26)
Intellectual property (111)
Interviews (18)
IPO (7321)
IRA (12)
Job creations (866)
Job search strategy (127)
Kidney cancer (8)
Labor market (15)
Layoffs (231)
Leadership (5)
Legal (1401)
Liver cancer (37)
Longevity (8)
Lung cancer (313)
Lymphoma (158)
Machine learning (12)
Management (7)
Manufacturing (236)
MASH (88)
Medical device (2636)
Medtech (2640)
Mergers & acquisitions (6414)
Metabolic disorders (535)
Multiple sclerosis (75)
NASH (13)
Neurodegenerative disease (116)
Neuropsychiatric disorders (34)
Neuroscience (1553)
NextGen: Class of 2025 (2025)
Non-profit (858)
Now hiring (26)
Obesity (249)
Opinion (110)
Ovarian cancer (91)
Pain (67)
Pancreatic cancer (97)
Parkinson's disease (161)
Partnered (9)
Patents (215)
Patient recruitment (175)
Peanut (39)
People (26119)
Pharmaceutical (46)
Pharmacy benefit managers (5)
Phase I (14905)
Phase II (19627)
Phase III (12379)
Pipeline (1558)
Policy (76)
Postmarket research (854)
Preclinical (6324)
Press Release (30)
Prostate cancer (96)
Psychedelics (44)
Radiopharmaceuticals (221)
Rare diseases (409)
Real estate (1430)
Recruiting (12)
Regulatory (9136)
Reports (19)
Research institute (946)
Resumes & cover letters (17)
Rett syndrome (10)
RNA editing (15)
RSV (12)
Schizophrenia (93)
Series A (126)
Series B (92)
Service/supplier (1)
Sickle cell disease (56)
Special edition (15)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (1992)
State (1)
Stomach cancer (5)
Supply chain (27)
Tariffs (16)
The Weekly (51)
Vaccines (283)
Venture capital (44)
Weight loss (134)
Women's health (18)
Worklife (2)
Date
Today (70)
Last 7 days (238)
Last 30 days (1263)
Last 365 days (18499)
2025 (12821)
2024 (20559)
2023 (22422)
2022 (26830)
2021 (27813)
2020 (23363)
2019 (16240)
2018 (11745)
2017 (13766)
2016 (11857)
2015 (14355)
2014 (10398)
2013 (7488)
2012 (7534)
2011 (7615)
2010 (7430)
Location
Africa (151)
Alabama (57)
Alaska (2)
Arizona (59)
Arkansas (5)
Asia (17759)
Australia (3008)
California (5396)
Canada (1482)
China (548)
Colorado (203)
Connecticut (204)
Delaware (158)
Europe (38136)
Florida (678)
Georgia (171)
Hawaii (2)
Idaho (16)
Illinois (310)
India (18)
Indiana (120)
Iowa (7)
Japan (136)
Kansas (71)
Kentucky (6)
Louisiana (4)
Maine (11)
Maryland (597)
Massachusetts (4283)
Michigan (89)
Minnesota (201)
Mississippi (3)
Missouri (26)
Montana (14)
Nebraska (4)
Nevada (25)
New Hampshire (15)
New Jersey (1305)
New Mexico (12)
New York (1392)
North Carolina (694)
North Dakota (6)
Northern California (2481)
Ohio (143)
Oklahoma (9)
Oregon (21)
Pennsylvania (996)
Puerto Rico (7)
Rhode Island (24)
South America (210)
South Carolina (6)
Southern California (2100)
Tennessee (31)
Texas (681)
United States (18140)
Utah (76)
Virginia (113)
Washington D.C. (36)
Washington State (450)
West Virginia (1)
Wisconsin (27)
274,777 Results for "repare therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
August 8, 2025
·
11 min read
Press Releases
Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
July 16, 2025
·
7 min read
Press Releases
Repare Therapeutics Announces Leadership Transitions
April 1, 2025
·
6 min read
Press Releases
Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
May 2, 2025
·
6 min read
Press Releases
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
May 14, 2025
·
10 min read
Press Releases
Repare Therapeutics Announces Six Abstracts Accepted for Presentation at AACR Annual Meeting 2025
April 25, 2025
·
3 min read
Business
Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today reported financial results for the first quarter ended March 31, 2024.
May 7, 2024
·
13 min read
Genetown
Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 2:40 p.m. Eastern Time in Miami, FL.
June 3, 2024
·
1 min read
Press Releases
Repare Therapeutics Announces Portfolio Re-Prioritization, Partnering Initiatives and Cost Reductions
January 10, 2025
·
8 min read
1 of 27,478
Next
